On April 15th the Wall Street Journal reported that Johnson &Johnson (J&J), a giant health-care company, was in talks to buy Synthes, a medical-device maker.
本月15日，华尔街日报报道了保健业巨头⎯强生与医疗器材制造商⎯辛迪思洽谈收购事宜。
Johnson & Johnson's ($JNJ) stellar year for drug approvals continues. U. S. regulators have given a market nod to J&J unit Janssen's extended-release version of pain pill Nucynta.
强生公司的止痛药现已再次获得FDA批准上市，美国官方已经允许强生将该药Nucynta投放市场中。
Johnson & Johnson's ($JNJ) stellar year for drug approvals continues. U. S. regulators have given a market nod to J&J unit Janssen's extended-release version of pain pill Nucynta.
强生公司的止痛药现已再次获得FDA批准上市，美国官方已经允许强生将该药Nucynta投放市场中。
应用推荐